期刊文献+

血管型白塞病的外科治疗现状 被引量:3

Current Surgical Treatment of Vasculo-Behcet′s Disease
暂未订购
导出
摘要 白塞病是一种自身免疫性疾病,可分为血管型、胃肠型及神经型。其中血管型白塞病常导致较高的致死率及致残率。白塞病合并动脉瘤破裂未经诊治后果严重,病死率极高。白塞病的病因至今不明,中性粒细胞的异常活动被认为是白塞病的主要发病机制。血管型白塞病的治疗应在药物治疗控制疾病活动期的基础上实行正确的手术干预。正确的手术能提高患者近期生存率,提高生活质量。现就血管型白塞病外科治疗的最新进展进行综述。 Behcet′s disease(BD)is an autoimmune system disease,which can be classified into vascular,gastrointestinal and neurological type.Vascular type BD usually has relatively high mortality and morbidity.BD patients with aneurysm rupture would have very high mortality and poor prognosis without proper treatment.The etiology of BD remains unclear,while the abnormal activities of neutrophils is considered to be the main pathogenesis.Based on medication control of active phase,the treatment of vascular type BD should also include appropriate surgical intervention,which could improve short term survival and the prognosis.Here is to make a review on the recent progress of surgical treatments for vascular type BD.
出处 《医学综述》 2012年第9期1360-1362,共3页 Medical Recapitulate
关键词 白塞病 外科治疗 血管并发症 动脉瘤 Behcet′s disease Surgical treatment Vascular complications Arterial aneurysm
  • 相关文献

参考文献1

二级参考文献23

  • 1Wallis S, Macierewicz J, Shrestha BM. Behcet's disease:Report of a case and review of the literature [ J ]. JNMA J Nepal Med Assoc ,2006,45 ( 164 ) :362-365.
  • 2McDonald DR, Lee C, Fowler RA, et al. Behcet' s disease [ J ]. CMAJ,2007,176 ( 9 ) : 1273-1274.
  • 3Niedzielska A, Chelminska K, Jaremin B. Behcet's disease-diagnostic difficulties [ J ]. Pol Arch Med Wewn, 2007, 117 ( 9 ) : 427-429.
  • 4Salas Cabrera R, Sague Larrea J, Laurencio Mena A. Bechet's disease [ J ]. Case Report Arch Esp Urol,2007,60 ( 1 ) : 67-68.
  • 5Hirohata S. Histopathology of central nervous system lesions in Behcet' s disease [ J ]. J Neurol Sci, 2008,267 ( 1/2 ) : 41-47.
  • 6Ahn JK,Park YG. Human leukocyte antigen B27 and B51 double-positive Behcet uveitis [ J ]. Arch Ophthalmol, 2007, 125 (10) : 1375-1380.
  • 7Amoura Z, Guillaume M, Caillat-Zucman S,et al. Pathophysiology of Behcet's disease[J]. Rev Med Interne, 2006,27 (11): 843-853.
  • 8Guillaume-Czitrom S, Berger C, Pajot C,et al. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease [ J ]. Rheumatology (Oxford) , 2007, 46(10) :1570-1573.
  • 9Thirion M, Miceli-Richard C, Labetoulle M,et al. Low dose interferon-alpha to treat Behcet' s disease [ J ]. Clin Exp Rheumatol, 2007,25(5) :791.
  • 10Takamoto M, Kaburaki T, Numaga J, et al. Long-term intliximab treatment for Behcet' s disease [ J ]. Jpn J Ophthalmol, 2007,51 ( 3 ) :239-240.

共引文献10

同被引文献11

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部